Calidi Biotherapeutics Future Growth
Future criteria checks 0/6
Calidi Biotherapeutics's earnings are forecast to decline at 5.6% per annum. EPS is expected to grow by 61.3% per annum.
Key information
-5.6%
Earnings growth rate
61.3%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 21 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -26 | N/A | -39 | 2 |
| 12/31/2025 | N/A | -23 | N/A | -32 | 2 |
| 12/31/2024 | N/A | -25 | N/A | -27 | 2 |
| 9/30/2024 | N/A | -28 | -20 | -19 | N/A |
| 6/30/2024 | N/A | -25 | -28 | -28 | N/A |
| 3/31/2024 | N/A | -30 | -28 | -28 | N/A |
| 12/31/2023 | N/A | -29 | -28 | -27 | N/A |
| 9/30/2023 | N/A | -29 | -26 | -26 | N/A |
| 6/30/2023 | N/A | -32 | -17 | -16 | N/A |
| 3/31/2023 | N/A | -24 | -15 | -14 | N/A |
| 12/31/2022 | 0 | -25 | -14 | -13 | N/A |
| 9/30/2022 | 0 | -21 | -12 | -12 | N/A |
| 12/31/2021 | 0 | -11 | -8 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLDI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CLDI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CLDI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if CLDI's revenue is forecast to grow faster than the US market.
High Growth Revenue: CLDI is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CLDI's Return on Equity is forecast to be high in 3 years time